Avalyn Pharma Inc. (AVLN) SEC filings
AVLNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$30.28−0.31 (-1.01%)
Close on Nov 13, 2026Market cap $1.34BP/E –Yield –
SEC filings
10 of Avalyn Pharma's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Sep 30, 2026 | Nov 12, 2026 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2026 | Nov 12, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2026 | Sep 16, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2026 | Aug 12, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 29, 2026 | Jul 1, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 17, 2026 | Jun 17, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 3, 2026 | Jun 3, 2026 | SEC EDGAR |
| Current report | 8-K | May 1, 2026 | May 1, 2026 | SEC EDGAR |
See a number that looks wrong?